MedTrace Logo

Low Intensity Extracorporeal Shockwave Therapy for Patients With Erectile Dysfunction

NCT02005731 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2014-06-11

No results posted yet for this study

Summary

This is a prospective, pilot study for assessing the safety and efficacy of the treatments performed with Renova (LI-ESWT) on symptomatic ED patients.

Conditions

  • Vasculogenic Erectile Dysfunction

Interventions

DEVICE

Low intensity linear focused shockwave device ('Renova')

Sponsors & Collaborators

  • Initia

    lead INDUSTRY

Principal Investigators

  • Cobi Reisman, MD, PhD · Men's Health Clinic, Amstelland Hospital, Amsterdam, The Netherlands

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • Czechia
  • Lithuania
  • Netherlands
  • Palestinian Territories

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02005731 on ClinicalTrials.gov